TickerFactsScreenerDevelopers

GYRE THERAPEUTICS, INC. (GYRE) — Operating Income

Annual figures by fiscal year, from SEC filings.

2009: -$40.33M2010: $13.12M2011: -$9.74M2012: -$8.14M2013: -$10.12M2014: -$7.51M2015: -$13.80M2016: -$20.42M2017: -$21.82M2018: -$33.82M2019: -$57.28M2020: -$57.37M2021: -$87.89M2022: $9.20M2023: -$67.23M2024: $16.16M2025: $11.49M$11.49M
2009Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025$11.49M-28.9%
2024$16.16M+124.0%
2023-$67.23M-830.5%
2022$9.20M+110.5%
2021-$87.89M-53.2%
2020-$57.37M-0.2%
2019-$57.28M-69.3%
2018-$33.82M-55.0%
2017-$21.82M-6.9%
2016-$20.42M-47.9%
2015-$13.80M-83.8%
2014-$7.51M+25.8%
2013-$10.12M-24.4%
2012-$8.14M+16.5%
2011-$9.74M-174.3%
2010$13.12M+132.5%
2009-$40.33M—